X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   TEVA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
TEVA PHARMA
Dec-13
UNICHEM LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3822,882-   
Low Rs2342,503-   
Sales per share (Unadj.) Rs116.31,653.9-  
Earnings per share (Unadj.) Rs-18.9103.3-  
Cash flow per share (Unadj.) Rs-11.7237.0-  
Dividends per share (Unadj.) Rs5.0090.44-  
Dividend yield (eoy) %1.63.4 48.3%  
Book value per share (Unadj.) Rs381.01,837.1-  
Shares outstanding (eoy) m70.34848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.6 162.7%   
Avg P/E ratio x-16.326.1 -62.5%  
P/CF ratio (eoy) x-26.211.4 -231.0%  
Price / Book Value ratio x0.81.5 55.2%  
Dividend payout %-26.487.5 -30.2%   
Avg Mkt Cap Rs m21,6682,283,291 0.9%   
No. of employees `0002.344.9 5.1%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.831,204.3 11.5%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.71,949.3 -29.9%   
INCOME DATA
Net Sales Rs m8,1801,402,479 0.6%  
Other income Rs m6100-   
Total revenues Rs m8,7901,402,479 0.6%   
Gross profit Rs m-1,320384,070 -0.3%  
Depreciation Rs m505113,364 0.4%   
Interest Rs m8027,547 0.3%   
Profit before tax Rs m-1,295243,159 -0.5%   
Minority Interest Rs m01,105 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-159,620 0.0%   
Tax Rs m33-2,969 -1.1%   
Profit after tax Rs m-1,33187,612 -1.5%  
Gross profit margin %-16.127.4 -58.9%  
Effective tax rate %-2.6-1.2 211.3%   
Net profit margin %-16.36.2 -260.5%  
BALANCE SHEET DATA
Current assets Rs m23,318947,229 2.5%   
Current liabilities Rs m4,635826,064 0.6%   
Net working cap to sales %228.48.6 2,643.6%  
Current ratio x5.01.1 438.7%  
Inventory Days Days12291 134.1%  
Debtors Days Days12196 126.6%  
Net fixed assets Rs m8,163458,080 1.8%   
Share capital Rs m1413,452 4.1%   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8011,557,888 1.7%   
Long term debt Rs m3717,118 0.0%   
Total assets Rs m31,8903,205,113 1.0%  
Interest coverage x-15.29.8 -154.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.4 58.6%   
Return on assets %-3.93.6 -109.2%  
Return on equity %-5.05.6 -88.3%  
Return on capital %-4.54.9 -92.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123223,482 -0.5%  
From Investments Rs m16,487-79,189 -20.8%  
From Financial Activity Rs m-8,811-268,082 3.3%  
Net Cashflow Rs m6,552-123,789 -5.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.04 Rs / USD

Compare UNICHEM LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare UNICHEM LAB With: MERCK  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Get Ready for Record Highs(Podcast)

Globally, Traders were left scrambling after the Federal Reserve forecast zero interest-rate hikes this year and just one in 2020.

Related Views On News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 22, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS